What Is Carbamazepine?
Carbamazepine is an anticonvulsant medication that's the first-line treatment for trigeminal neuralgia (TN), a condition causing severe facial pain. It works by stabilizing nerve membranes and reducing abnormal electrical activity. Brand names include Tegretol and Carbatrol.1
How It Works2
- Blocks sodium channels
- Stabilizes nerve cell membranes
- Reduces nerve firing
- Prevents pain signal transmission
- Most effective for lancinating pain
Primary Pain Uses
- Trigeminal neuralgia (gold standard)
- Glossopharyngeal neuralgia
- Other paroxysmal nerve pain
Other Uses
- Epilepsy
- Bipolar disorder
- Some other neuropathic pain
Dosing3
- Start low: 100-200 mg twice daily
- Increase slowly over weeks
- Typical maintenance: 400-1200 mg/day
- Extended-release available
- Blood level monitoring recommended
Common Side Effects
- Dizziness
- Drowsiness
- Nausea
- Unsteadiness
- Double vision
- Headache
- Often improve with time
Serious Risks
- Severe skin reactions (SJS/TEN)
- Bone marrow suppression
- Liver problems
- Low sodium (especially elderly)
- Heart rhythm changes
Important Precautions
- Genetic testing recommended for some
- HLA-B*1502 increases skin reaction risk
- Regular blood monitoring needed
- Many drug interactions
- Induces its own metabolism
- Affects hormonal birth control
Monitoring Requirements
- Complete blood count
- Liver function tests
- Sodium levels
- Drug levels (sometimes)
- More frequent initially
Effectiveness for TN
- 70-80% get significant relief
- Response helps confirm diagnosis
- May need dose adjustments over time
- Some develop tolerance
Alternatives
- Oxcarbazepine (often better tolerated)
- Baclofen (can combine)
- Lamotrigine
- Surgical options for refractory cases
References
- Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15(10):1013-1028.
- Wiffen PJ, Derry S, Moore RA, Kalso EA. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014;(4):CD005451.
- Bendtsen L, Zakrzewska JM, Abbott J, et al. European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26(6):831-849.